Customized Care, Optimal Health: Navigating the Compounding Pharmacies Market's Personalized Medicine Revolution

The Compounding Pharmacies Market report by Persistence Market Research goes by the changing trend of consumerism all across the healthcare vertical. “Going cashless” is amongst the “new” normals. Inorganic growth has also picked up. Key participants of the healthcare value chain – both – private and public – have joined hands for competing in the ever-demanding landscape.

Compounding pharmacies produce personalized medicines that can be altered by dosages, medicinal strengths, forms, and medium of administration, under the guidance of licensed pharmacists and physicians. The market for compounding pharmacies – though shrouded by regulatory restrictions and product quality conformations – presents a lucrative opportunity, as compounded drugs offer ease of accessibility, affordability, and administration to potential customers.

The global market for compounding pharmacies generated around US$ 10.3 billion in revenue in 2022, and is expected to grow at a CAGR of 8.6% to reach a valuation of US$ 25.4 billion by the end of 2033.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/5270

Companies covered in Compounding Pharmacies Market Report

• Fagron
• Fresenius Kabi AG
• PharMEDium Services, LLC
• Institutional Pharmacy Solutions
• Cantrell Drug Company
• Lorraine’s Pharmacy
• Braun Melsungen AG

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/5270

Key Takeaways from Compounding Pharmacies Market Study

• Among the therapeutic segments, compounding pharmacies find the largest application in the pain management industry, followed by hormone replacement therapy and others. The hormone replacement therapy segment is expected to gain traction in the near future, due to increasing demand for anti-ageing solutions.
• Growing demand for high-quality dermatological products is also influencing manufacturers to opt for better quality active pharmaceutical ingredients and maintain a sterile microbial contamination-free manufacturing space. Creams and gels are the most popular products in dermatology, followed by transdermal application products, largely popular in tropical countries.
• By application, the compounding pharmacies market is segmented into medications for adults, children, and geriatric population, along with veterinary drugs. Medications for the adult segment are expected to dominate the overall compounding pharmacies market by the end of the forecast period. However, veterinary compounded drugs are also gaining traction, as these drugs are available in alternate forms and in varying strengths that are not commercially available.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/5270

“Due to the rampant spread of COVID-19 across the world, physician visits and hospitalization for other reasons have seen a sharp decline. As a result, the global compounding pharmacies market will experience short-term negative growth over these months,” says a PMR analyst.

What Does the Future Hold?

The use of compounded drugs has been increasing at 3–6% globally, driven by shortage of essential medicines for critical diseases such as cardiovascular disease, cancer, diabetes, Lyme disease, and tuberculosis. This prompts the use of readily-available compounded medications, be it from a registered or unregistered facility, improves instant accessibility to drugs. Medicinal drought is more prominent in the U.S. as compared to other regions. The global compounding pharmacies market is set for decent growth due to factors such as upcoming products and therapeutic areas, diversification of services, increasing FDA compliance, rising incidence of medicinal drought of prescription medications, upsurge in demand for topical drugs, and the availability of these drugs in alternate dosage forms and combined formulations.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on the compounding pharmacies market in its latest study, presenting historical demand assessment of 2018–2022 and projections for 2023–2033, based on product type (oral medication, topical medication, mouthwashes, and suppositories), application (medication for adults, medication for veterinary, medication for children, and medication for geriatrics), and therapeutic area (pain management and hormone replacement therapy), across seven key regions.

Explore Extensive Coverage of Persistence Market Research’s Healthcare Industry

For More Related Reports –

https://www.persistencemarketresearch.com/market-research/umbilical-cord-blood-banking-market.asp

https://www.persistencemarketresearch.com/market-research/delivery-systems-in-personal-care-market.asp

https://www.persistencemarketresearch.com/market-research/hemoglobinopathy-market.asp

https://www.persistencemarketresearch.com/market-research/diabetic-foot-ulcer-therapeutics-market.asp

About us: –

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductors and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com